286 related articles for article (PubMed ID: 29638159)
41. Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus.
Peixoto EB; Papadimitriou A; Lopes de Faria JM; Lopes de Faria JB
Nephron Exp Nephrol; 2012; 120(2):e81-90. PubMed ID: 22555049
[TBL] [Abstract][Full Text] [Related]
42. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
43. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
44. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
46. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
[TBL] [Abstract][Full Text] [Related]
47. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
Lian H; Cheng Y; Wu X
Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
Liu Y; Xu Z; Ma F; Jia Y; Wang G
Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
[TBL] [Abstract][Full Text] [Related]
49. Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
Matoba K; Kawanami D; Nagai Y; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820432
[TBL] [Abstract][Full Text] [Related]
50. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
[No Abstract] [Full Text] [Related]
51. Grape seed proanthocyanidin extracts ameliorate podocyte injury by activating peroxisome proliferator-activated receptor-γ coactivator 1α in low-dose streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats.
Bao L; Cai X; Dai X; Ding Y; Jiang Y; Li Y; Zhang Z; Li Y
Food Funct; 2014 Aug; 5(8):1872-80. PubMed ID: 24941909
[TBL] [Abstract][Full Text] [Related]
52. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
[TBL] [Abstract][Full Text] [Related]
53. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
[TBL] [Abstract][Full Text] [Related]
54. Effect of osthole on advanced glycation end products-induced renal tubular hypertrophy and role of klotho in its mechanism of action.
Kan WC; Hwang JY; Chuang LY; Guh JY; Ye YL; Yang YL; Huang JS
Phytomedicine; 2019 Feb; 53():205-212. PubMed ID: 30668400
[TBL] [Abstract][Full Text] [Related]
55. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
56. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
Lin W; Zhang Q; Liu L; Yin S; Liu Z; Cao W
Kidney Int; 2017 Sep; 92(3):669-679. PubMed ID: 28416226
[TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway.
Yang YL; Xue M; Jia YJ; Hu F; Zheng ZJ; Wang L; Si ZK; Xue YM
Exp Mol Med; 2020 Feb; 52(2):266-280. PubMed ID: 32054986
[TBL] [Abstract][Full Text] [Related]
58. Changes of podocyte p130Cas in diabetic conditions.
Ha TS; Choi JY; Park HY; Han GD
J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
[TBL] [Abstract][Full Text] [Related]
59. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
60. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells.
Jung DS; Li JJ; Kwak SJ; Lee SH; Park J; Song YS; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim YS; Han DS; Kang SW
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F595-604. PubMed ID: 18524857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
